Innovations In: Gene Therapy
After facing early challenges, the field is moving toward the medical mainstream
This special report is editorially independent and was produced with financial support from Pfizer.
After facing early challenges, the field is moving toward the medical mainstream
This special report is editorially independent and was produced with financial support from Pfizer.
Various approaches are approved for treating blood cancers and a few rare disorders—they may soon become standard care
Over the past few years, the discipline has evolved in significant ways
Tragic side effects plagued the field’s early years, but researchers are finding ways to minimize the risks